Home > Pill Identifier > APAP 500 MG / Chlorpheniramine Maleate 2 MG / Phenylephrine Hydrochloride 5 MG Oral Tablet

Pill Identifier Information of APAP 500 MG / Chlorpheniramine Maleate 2 MG / Phenylephrine Hydrochloride 5 MG Oral Tablet

Drug Information

APAP 500 MG / Chlorpheniramine Maleate 2 MG / Phenylephrine Hydrochloride 5 MG Oral Tablet

Imprint: PAC
Shape: C48336
Color: C48330
Ingredients: Acetaminophen; Chlorpheniramine; Phenylephrine
Size: 17.00
Score: 1
Rxtty: SY
Author: Hybrid-Rx LLC
Inactive Ingredients: D&C YELLOW NO. 10 / FD&C YELLOW NO. 6 / HYPROMELLOSE 2910 (15 CPS) / TRIACETIN / POVIDONE / STEARIC ACID / CELLULOSE, MICROCRYSTALLINE>

Complete Information

  • ACTIVE INGREDIENT


    Active Ingredients (in each caplet)
    Acetaminophen 500 mg
    Chlorpheniramine maleate 2 mg
    Phenylephrine HCl 5 mg
  • PURPOSE

    Purposes
    Pain reliever/Fever Reducer
    Antihistamine
    Nasal Decongestant


  • DOSAGE & ADMINISTRATION

    Directions

    Adults: Take 1 to 2 caplets with water every 6 hours as needed; do not take more than 8 caplets in 24 hours or as directed by a doctor.

  • INACTIVE INGREDIENT

    Enter section text here

  • QUESTIONS

    Questions? 1-904-367-8437, Monday-Friday, 9am-5pm EST

  • Warnings

    Liver warning: This product contains acetaminophen.  Severe liver damage may occur if you take

    more than 8 caplets in 24 hours

    with other drugs containing acetaminophen

    3 or more alcoholic drinks every day while using this product

    Alcohol warning: If you consume 3 or more alcoholic drinks every day, ask your doctor whether you should take acetaminophen or other pain relievers/fever reducers.  Acetaminophen may cause liver damage.

  • Do Not Use

    • if you are now taking a prescription monoamine oxidase inhibitor (MAOI) (certain drugs for depression, psychiatric or emotional conditions, or Parkinson's disease), or for 2 weeks after stopping the MAOI drug.  If you do not know if your prescription drug contains an MAOI, ask a doctor or pharmacist before taking this product 
    • with any other product containing any of the above active ingredients.
    • with any other drug containing acetaminophen (prescription or nonprescription).
    • Ask a doctor or pharmacist before using with other drugs if you are not sure.
  • Ask a doctor before use if you have

    • liver disease
    • heart disease
    • high blood pressure
    • thyroid disease
    • diabetes
    • glaucoma
    • trouble urinating due to an enlarged prostate gland
    • a breathing problem such as emphysema or chronic bronchitis
  • Ask a doctor or pharmacist before use if

    you are taking sedatives or tranquilizers.

  • When using this product

    • do not use more than directed
    • excitability may occur, especially in children
    • drowsiness may occur
    • avoid alcoholic drinks
    • alcohol, sedatives and tranquilizers may increase the drowsiness
    • use caution when driving a motor vehicle or operating machinery
  • Stop use and ask a doctor if

    • you get nervous, dizzy or sleepless
    • redness of swelling is present
    • new symptoms occur
    • symptoms get worse or last for more than 7 days
    • fever gets worse or lasts more than 3 days
  • If pregnant or breast feeding

    ask a health professional before use.

  • Keep out of reach of children

    In case of overdose, get medical help or contact a Poison Control Center immediately.  Prompt medical attention is critical for adults as well as for children even if you do not notice any signs or symptoms.

  • Hybrid CF

    aada0b4d-1776-48e5-98e2-a2e769279c5a.jpg

    Principal Display Panel

  • INGREDIENTS AND APPEARANCE
    HYBRID CF 
    apap 500 mg phenylephrine hcl 5 mg chlorpheniramine maleate 2 mg tablet, film coated
    Product Information
    Product TypeHUMAN OTC DRUGItem Code (Source)NDC:49804-101(NDC:62959-116)
    Route of AdministrationORAL
    Active Ingredient/Active Moiety
    Ingredient NameBasis of StrengthStrength
    ACETAMINOPHEN (UNII: 362O9ITL9D) (ACETAMINOPHEN - UNII:362O9ITL9D) ACETAMINOPHEN500 mg
    PHENYLEPHRINE HYDROCHLORIDE (UNII: 04JA59TNSJ) (PHENYLEPHRINE - UNII:1WS297W6MV) PHENYLEPHRINE5 mg
    CHLORPHENIRAMINE MALEATE (UNII: V1Q0O9OJ9Z) (CHLORPHENIRAMINE - UNII:3U6IO1965U) CHLORPHENIRAMINE2 mg
    Inactive Ingredients
    Ingredient NameStrength
    D&C YELLOW NO. 10 (UNII: 35SW5USQ3G)  
    FD&C YELLOW NO. 6 (UNII: H77VEI93A8)  
    HYPROMELLOSE 2910 (15 CPS) (UNII: 36SFW2JZ0W)  
    TRIACETIN (UNII: XHX3C3X673)  
    POVIDONE (UNII: FZ989GH94E)  
    STEARIC ACID (UNII: 4ELV7Z65AP)  
    CELLULOSE, MICROCRYSTALLINE (UNII: OP1R32D61U)  
    Product Characteristics
    ColoryellowScoreno score
    ShapeCAPSULESize17mm
    FlavorImprint Code PAC
    Contains    
    Packaging
    #Item CodePackage DescriptionMarketing Start DateMarketing End Date
    1NDC:49804-101-241 in 1 CARTON
    112 in 1 BLISTER PACK
    Marketing Information
    Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
    OTC monograph finalpart34102/03/2010
    Labeler - Hybrid-Rx LLC (794846191)
© 2026 - Pharmaguru.com. All rights reserved.